MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Depression, apathy, fatigue in Parkinson with or without STN DBS

L. Al-Nakeeb, M. Panisset (Montreal, QC, Canada)

Meeting: 2018 International Congress

Abstract Number: 1795

Keywords: Apathy, Depression, Subthalamic nucleus(SIN)

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Psychiatric Manifestations

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: To determine the prevalence of depression, evaluate the relationship between depression, apathy and fatigue, and the impact of STN DBS on the same symptoms.

Background: The prevalence of depression in PD varies from 4 to 70%, that of apathy is about 60% and that of fatigue is 58%. Apathy often coexists with depression, but can also exist independently. Apathy is thought to be related to a dysfunction of the gratification/motivation system. The impact of STN DBS on depression, apathy and fatigue is controversial.

Methods: Patients with probable PD were selected. Validated self-questionnaires for PD on depression (Beck II), apathy and fatigue were used. Patients were segregated according to cut off scores as being symptomatic or not and according to DBS status. DBS and non-DBS patients were matched according to disease duration. Comparisons were made using Mann-Whitney-U test.

Results: Out of 297 contacted patients, 50 completed the three questionnaires and 87 at least the depression questionnaire. The population mean age was 67.0 ± 7.93 years. 21 patients (disease duration 16.05 ± 4.7 years) had had DBS and 12 (13.4 ± 4.7) not. 48% of the 87 participants had a score of at least 14 on the Beck II (depressed). Half of them were already treated with anti-depressants. 47% were not depressed but on antidepressants and the remaining 5% were not depressed and on no anti-depressant. Depressed patients had significantly more apathy (p<0.0001) and fatigue (p<0.0001) than non depressed patients. Apathetic patients had more depression (p=0.0002) and more fatigue (p=0.0021); and patients with fatigue had more apathy (p<0.0001) and depression (p=0.0064). There was no difference in depression and fatigue between STN DBS and non STN DBS patients, but operated patients had more apathy (p=0.0094).

Conclusions: In our study, only 5% are likely not to have experienced depression. Depression is under diagnosed and under treated as half of depressed patients are not treated and half is depressed in spite of anti-depressant therapy. Depression, apathy and fatigue are closely interconnected. Nevertheless, STN DBS is only associated to an increase in apathy. This supports the specificity of this symptom against fatigue and depression, and suggests that the STN may be important in the gratification/motivation system. Results from this study need to be interpreted with caution as the n is small and because of its retrospective nature.

To cite this abstract in AMA style:

L. Al-Nakeeb, M. Panisset. Depression, apathy, fatigue in Parkinson with or without STN DBS [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/depression-apathy-fatigue-in-parkinson-with-or-without-stn-dbs/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/depression-apathy-fatigue-in-parkinson-with-or-without-stn-dbs/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley